Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx

NCT00051441 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

605

Enrollment

INDUSTRY

Sponsor class

Conditions

Stomatitis
Radiation Effects

Interventions

DRUG: Benzydamine Hydrochloride 0.15% Oral Rinse

Sponsor

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Collaborators

[object Object]